The 19 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 42.08, with a high estimate of 54.38 and a low estimate of 35.31. The median estimate represents a +3.71% increase from the last price of 40.57.
The current consensus among 25 polled investment analysts is to Hold stock in GlaxoSmithKline PLC. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.56
Reporting Date TBD
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.